PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic JournalOpen Access

Frontiers in Neuroergonomics

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Frontiers in Neuroergonomics has 1 tracked paper indexed in Blossom (2022) from 7 authors, most often covering Psilocybin, across Healthy Volunteers, Neuroimaging & Brain Measures and Anxiety Disorders.

Published Papers

Open Accessindividual

Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

Using [11C]MDL 100,907 PET and resting‑state fMRI‑derived cortical parcellation in four healthy volunteers, a single oral psychoactive dose of psilocybin produced mean cortical 5‑HT2A receptor occupancy of 39.5% (±10.9%), with the highest occupancy (63–75%) in default mode network regions (subgenual anterior cingulate and bilateral angular gyri). Significant inter‑individual variability was observed, supporting further study of how regional 5‑HT2A occupancy relates to acute and lasting effects of psilocybin.

Published
January 20, 2022
Journal
Frontiers in Neuroergonomics
Authors
Barrett, F. S., Zhou, Y., Carbonaro, T. M., Roberts, J. M., Smith, G. S., Griffiths, R. R., Wong, D. F.

Quick Facts

Papers Indexed
1
h-Index
12
Open Access
Yes
Publisher
Frontiers Media
Country
Switzerland
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.